Time-resolved scRNA-seq reveals transcription dynamics of polarized macrophages with influenza A virus infection and antigen presentation to T cells
Throughout history, the influenza A virus has caused numerous devastating global pandemics. Macrophages, as pivotal innate immune cells, exhibit a wide range of immune functions characterized by distinct polarization states, reflecting their intricate heterogeneity. In this study, we employed the time-resolved single-cell sequencing technique coupled with metabolic RNA labelling to elucidate the dynamic transcriptional changes in distinct polarized states of bone marrow-derived macrophages (BMDMs) upon infection with the influenza A virus. Our approach not only captures the temporal dimension of transcriptional activity, which is lacking in conventional scRNA-seq methods, but also reveals that M2-polarized <i>Arg1</i>_macrophage cluster is the sole state supporting successful replication of influenza A virus. Furthermore, we identified distinct antigen presentation capabilities to CD4<b><sup>+</sup></b> T and CD8<b><sup>+</sup></b> T cells across diverse polarized states of macrophages. Notably, the M1 phenotype, exhibited by (BMDMs) and murine alveolar macrophages (AMs), demonstrated superior conventional and cross-presentation abilities for exogenous antigens, with a particular emphasis on cross-presentation capacity. Additionally, as CD8<b><sup>+</sup></b> T cell differentiation progressed, M1 polarization exhibited an enhanced capacity for cross-presentation. All three phenotypes of BMDMs, including M1, demonstrated robust presentation to CD4<b><sup>+</sup></b> regulatory T cells, while displaying limited ability to present to naive CD4<sup>+</sup> T cells. These findings offer novel insights into the immunological regulatory mechanisms governing distinct polarized states of macrophages, particularly their roles in restricting the replication of influenza A virus and modulating antigen-specific T cell responses through innate immunity.
Authors
- Xiao Shang (ORCID: https://orcid.org/0000-0002-2524-4007)
- Xiaoyan Deng (ORCID: https://orcid.org/0000-0002-6394-4880)
- Ying Zheng (ORCID: https://orcid.org/0000-0002-1906-9660)
- Hui Li (ORCID: https://orcid.org/0000-0002-4611-7808)
- Rongling Zhang (ORCID: https://orcid.org/0000-0002-1527-5512)
- Yeming Wang (ORCID: https://orcid.org/0000-0003-4343-9606)
- Bin Cao (ORCID: https://orcid.org/0000-0001-8743-2743)
- Jiapei Yu
- Ju Jia
- Congcong Shang
- Hongyu Liu (ORCID: https://orcid.org/0000-0003-0359-1283)
- William J. Liu
- Hui Zhang (ORCID: https://orcid.org/0000-0003-1520-2433)
- Zeyi Wang (ORCID: https://orcid.org/0009-0007-9340-3907)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- Peking Union Medical College Hospital (CN)
- National Institute for Viral Disease Control and Prevention (CN)
- Beijing Friendship Hospital (CN)
- Center for Life Sciences (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Emerging Microbes & Infections
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1080/22221751.2024.2387450
- Citations
- 6
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.44
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences